{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T03:14:50Z","timestamp":1777950890448,"version":"3.51.4"},"reference-count":31,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T00:00:00Z","timestamp":1777852800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Society for Interventional Oncology (SIO) Interventional Oncology\/Immuno-oncology grant"},{"name":"NIH\/NCI Cancer Center","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background: Interventional radiology (IR) procedures may induce anti-tumor immune responses, with subsequent clonal expansion of specific T-cells recognizing tumor antigens. This exploratory study aims to investigate the clonal expansion of T-cells in the peripheral blood after interventional radiology procedures for metastatic liver cancer. Methods: This prospective study included 16 patients with metastatic liver cancer undergoing IR procedures (13 embolizations and 3 ablations). Biopsy samples were collected prior to the procedure, and peripheral blood samples were obtained both pre- and post-procedure. Bulk T-cell receptor (TCR) sequencing was conducted to assess T-cell clonality dynamics and to evaluate the impact of procedures on the T-cell repertoire. Results: The overall clonality of the T-cell repertoire in the peripheral blood did not demonstrate significant variations following IR procedures (p = 0.27\u20130.77). A subset of patients exhibited limited T-cell clonal expansion in peripheral blood one month after IR procedures, with more than 10 T-cell clonotypes expanding in 43% of patients. Most clonal expansions decreased in frequency by three months; however, 3 patients displayed persistently expanding T-cell clonotypes in peripheral blood \u2265 3 months following IR procedures. Conclusions: IR procedures do not alter the overall clonality of the T-cell repertoire but may promote the expansion of a limited number of clonotypes. This study demonstrates that it is feasible to detect and longitudinally track expanding T-cell clonotypes following IR liver-directed therapy. Further studies are needed to determine whether these expanding clonotypes contribute to systemic anti-tumor immunity.<\/jats:p>","DOI":"10.3390\/cancers18091477","type":"journal-article","created":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T08:29:34Z","timestamp":1777883374000},"page":"1477","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["T-Cell Clonal Expansion in Peripheral Blood Following Interventional Radiology Procedures for Metastatic Liver Cancer"],"prefix":"10.3390","volume":"18","author":[{"given":"Chenyang","family":"Zhan","sequence":"first","affiliation":[{"name":"Interventional Radiology Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1815-3799","authenticated-orcid":false,"given":"Anita","family":"Karimi","sequence":"additional","affiliation":[{"name":"Interventional Radiology Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7156-4004","authenticated-orcid":false,"given":"Leila","family":"Haghani","sequence":"additional","affiliation":[{"name":"Interventional Radiology Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brett","family":"Marinelli","sequence":"additional","affiliation":[{"name":"Interventional Radiology Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Tian","sequence":"additional","affiliation":[{"name":"Interventional Radiology Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Etay","family":"Ziv","sequence":"additional","affiliation":[{"name":"Interventional Radiology Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hooman","family":"Yarmohammadi","sequence":"additional","affiliation":[{"name":"Interventional Radiology Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erica S.","family":"Alexander","sequence":"additional","affiliation":[{"name":"Interventional Radiology Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7278-1369","authenticated-orcid":false,"given":"Vlasios S.","family":"Sotirchos","sequence":"additional","affiliation":[{"name":"Interventional Radiology Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Zhao","sequence":"additional","affiliation":[{"name":"Interventional Radiology Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3126-1193","authenticated-orcid":false,"given":"James W.","family":"Smithy","sequence":"additional","affiliation":[{"name":"Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8065-4412","authenticated-orcid":false,"given":"Alexander N.","family":"Shoushtari","sequence":"additional","affiliation":[{"name":"Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A.","family":"Scheinberg","sequence":"additional","affiliation":[{"name":"Center for Experimental Therapeutics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1876-727X","authenticated-orcid":false,"given":"Joseph P.","family":"Erinjeri","sequence":"additional","affiliation":[{"name":"Interventional Radiology Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,5,4]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/S0140-6736(21)01206-X","article-title":"Immune checkpoint inhibitors in melanoma","volume":"398","author":"Carlino","year":"2021","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1056\/NEJMoa1709684","article-title":"Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma","volume":"377","author":"Wolchok","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Bajestani, N., Wu, G., Hussein, A., and Makary, M.S. (2024). Examining the Efficacy and Safety of Combined Locoregional Therapy and Immunotherapy in Treating Hepatocellular Carcinoma. Biomedicines, 12.","DOI":"10.3390\/biomedicines12071432"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"7357","DOI":"10.1038\/s41467-024-51722-x","article-title":"Cryoablation and post-progression immune checkpoint inhibition in metastatic melanoma: A phase II trial","volume":"15","author":"Mooradian","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.jvir.2020.04.029","article-title":"Safety and Effectiveness of Yttrium-90 Radioembolization around the Time of Immune Checkpoint Inhibitors for Unresectable Hepatic Metastases","volume":"31","author":"Ruohoniemi","year":"2020","journal-title":"J. Vasc. Interv. Radiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jvir.2019.05.023","article-title":"Safety of Combined Yttrium-90 Radioembolization and Immune Checkpoint Inhibitor Immunotherapy for Hepatocellular Carcinoma","volume":"31","author":"Zhan","year":"2020","journal-title":"J. Vasc. Interv. Radiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/j.jvir.2018.04.030","article-title":"Combined Effects of Yttrium-90 Transarterial Radioembolization around Immunotherapy for Hepatic Metastases from Uveal Melanoma: A Preliminary Retrospective Case Series","volume":"29","author":"Zheng","year":"2018","journal-title":"J. Vasc. Interv. Radiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1148\/radiol.2019182326","article-title":"Immunotherapy and the Interventional Oncologist: Challenges and Opportunities\u2014A Society of Interventional Oncology White Paper","volume":"292","author":"Erinjeri","year":"2019","journal-title":"Radiology"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/j.jvir.2017.07.018","article-title":"Immuno-oncology and Its Opportunities for Interventional Radiologists: Immune Checkpoint Inhibition and Potential Synergies with Interventional Oncology Procedures","volume":"28","author":"Hickey","year":"2017","journal-title":"J. Vasc. Interv. Radiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jvir.2023.10.009","article-title":"Advances and Challenges in Interventional Immuno-Oncology Locoregional Therapies","volume":"35","author":"Altun","year":"2024","journal-title":"J. Vasc. Interv. Radiol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Ma, J., Wei, Z., and Ye, X. (2025). Interventional oncology and immunotherapy: Current status and future perspectives. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1541105"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.immuni.2013.07.012","article-title":"Oncology Meets Immunology: The Cancer-Immunity Cycle","volume":"39","author":"Chen","year":"2013","journal-title":"Immunity"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/s41577-018-0007-5","article-title":"Understanding the drivers of MHC restriction of T cell receptors","volume":"18","author":"Gras","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/ni1155","article-title":"The CDR3 regions of an immunodominant T cell receptor dictate the \u2018energetic landscape\u2019 of peptide-MHC recognition","volume":"6","author":"Borg","year":"2005","journal-title":"Nat. Immunol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1038\/s41591-018-0232-2","article-title":"Radiotherapy induces responses of lung cancer to CTLA-4 blockade","volume":"24","author":"Formenti","year":"2018","journal-title":"Nat. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1158\/2326-6066.CIR-16-0013","article-title":"Deep Sequencing of T-cell Receptor DNA as a Biomarker of Clonally Expanded TILs in Breast Cancer after Immunotherapy","volume":"4","author":"Page","year":"2016","journal-title":"Cancer Immunol. Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/s43018-019-0022-x","article-title":"Immune awakening revealed by peripheral T cell dynamics after one cycle of immunotherapy","volume":"1","author":"Valpione","year":"2020","journal-title":"Nat. Cancer"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/j.2040-4603.2013.tb00503.x","article-title":"Liver Immunology","volume":"3","author":"Bogdanos","year":"2013","journal-title":"Compr. Physiol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jvir.2023.10.019","article-title":"Immune Effects of Intra-Arterial Liver-Directed Therapies","volume":"35","author":"Karimi","year":"2024","journal-title":"J. Vasc. Interv. Radiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1007\/s00270-012-0506-x","article-title":"Pattern of Retained Contrast on Immediate Postprocedure Computed tomography (CT) After Particle Embolization of Liver Tumors Predicts Subsequent Treatment Response","volume":"36","author":"Wang","year":"2012","journal-title":"Cardiovasc. Interv. Radiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1038\/ncomms3680","article-title":"Using synthetic templates to design an unbiased multiplex PCR assay","volume":"4","author":"Carlson","year":"2013","journal-title":"Nat. Commun."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.copbio.2020.07.010","article-title":"T-cell repertoire analysis and metrics of diversity and clonality","volume":"65","author":"Chiffelle","year":"2020","journal-title":"Curr. Opin. Biotechnol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.4014\/jmb.1709.09027","article-title":"Deciphering Diversity Indices for a Better Understanding of Microbial Communities","volume":"27","author":"Kim","year":"2017","journal-title":"J. Microbiol. Biotechnol."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Rytlewski, J., Deng, S., Xie, T., Davis, C., Robins, H., Yusko, E., and Bienkowska, J. (2019). Model to improve specificity for identification of clinically-relevant expanded T cells in peripheral blood. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0213684"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41590-021-00985-3","article-title":"Significance of bystander T cell activation in microbial infection","volume":"23","author":"Lee","year":"2021","journal-title":"Nat. Immunol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"23721","DOI":"10.1073\/pnas.2001933117","article-title":"Radiation induces dynamic changes to the T cell repertoire in renal cell carcinoma patients","volume":"117","author":"Chow","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Montemurro, A., Jessen, L.E., and Nielsen, M. (2022). NetTCR-2.1: Lessons and guidance on how to develop models for TCR specificity predictions. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.1055151"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/s42003-021-02610-3","article-title":"NetTCR-2.0 enables accurate prediction of TCR-peptide binding by using paired TCR\u03b1 and \u03b2 sequence data","volume":"4","author":"Montemurro","year":"2021","journal-title":"Commun. Biol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.1440-1711.2006.01447.x","article-title":"Reverse immunology approach for the identification of CD8 T-cell-defined antigens: Advantages and hurdles","volume":"84","author":"Viatte","year":"2006","journal-title":"Immunol. Cell Biol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nri.2017.76","article-title":"Single-cell RNA sequencing to explore immune cell heterogeneity","volume":"18","author":"Papalexi","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/s41590-024-02059-6","article-title":"Integrating single-cell RNA and T cell\/B cell receptor sequencing with mass cytometry reveals dynamic trajectories of human peripheral immune cells from birth to old age","volume":"26","author":"Wang","year":"2025","journal-title":"Nat. Immunol."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/9\/1477\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T08:30:55Z","timestamp":1777883455000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/9\/1477"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,4]]},"references-count":31,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["cancers18091477"],"URL":"https:\/\/doi.org\/10.3390\/cancers18091477","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,4]]}}}